Biotechnology GBT to Host Investor Conference Call on Friday, June 10 and Participate in Upcoming Investor Conferences June 1, 2022
Biotechnology Axsome Therapeutics Announces Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05 in Major Depressive Disorder After Prior Treatment Failures at the American Society of Clinical Psychopharmacology (ASCP) 2022 Annual Meeting June 1, 2022
Search
Biotechnology
